Global Opioids Market By Drug Overview
Opioids Market was valued at USD 25.9 billion in 2024 and is projected to grow at a CAGR of 3.9% to reach USD 36. 60 billion by 2034.
An opioid is a type of narcotic pain medication that is used to treat moderate to severe pain either acute (short-term) or chronic (longer-term or continuous) pain. Opioid is used as a cough suppressant and diarrhea suppressant. It also reduces surgical pain, injury or trauma, and cancer pain. Increasing prevalence of chronic pain and orthopedic diseases is a major factor driving growth of the opioids market.
Rising usage of opioids in non-cancer conditions as well as increasing palliative care facilities and growing focus on Abuse-Deterrent Formulation (ADF) by generic manufacturers are some among the major factors expected to propel growth of the opioids market over the forecast period. Others applications of opioids such as analgesic use, antidiarrheal medicines, and cough suppressants are factors expected to promote growth of the opioids market over the forecast period. However, availability of legal alternative cannabis to the opioid is a key factor restraining growth of the opioids market.
Global Opioids Market By Drug Drivers & Restraints
Rising usage of opioids
Rising usage of opioids in non-cancer conditions as well as increasing palliative care facilities and growing focus on Abuse-Deterrent Formulation (ADF) by generic manufacturers are some among the major factors expected to propel growth of the global opioids market over the forecast period.
Others application of opioids
Others applications of opioids such as analgesic use, antidiarrheal medicines, and cough suppressants are factors expected to promote growth of the global opioids market over the forecast period. The increasing incidence of chronic pain is the major factors to foster the opioids market. The opioids are primarily used to treat the chronic pain. Further, the opioids are most prescribed by doctors for the choric pain. According to a study published by BMJ (British Medical Journal), in 2013, around one-third to one-half of the population in UK suffered from some kind of chronic pain. Further, according to study published in NCBI, the prevalence of chronic pain is estimated to be as high as 20% in Japan. Due to which, according to Center for Disease Control and Prevention has estimated that United States is the midst of an opioid overdose epidemic as opioids has killed more than 42,000 people in 2016 and from which 40% of all opioid overdose deaths involve a prescription opioid. This overdose epidemic has tightened the regulatory scenario for the prescription of opioid, which is expected to hamper the opioid market.However, availability of legal alternative cannabis to the opioid is a key factor restraining growth of the global opioids market.
Global Opioids Market By Drug Segmentations & Regional Insights
opioids market is segmented on the basis of drug class, therapeutic applications, and region.
- On the basis of drug type, the opioid market is segmented into agonist and antagonist. Antagonist sub-segment is bifurcated into codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromorphone, methylphenidate, oxycodone, and oxymorphone. Further, antagonist sub-segment is bifurcated into buprenorphine, naloxone, naltrexone, methylnaltrexone, and nalbuphine.
- On the basis of therapeutic application, the target market is segmented into pain management, cough treatment, and cough treatment. Pain management is sub-segmented into osteoarthritis pain, cancer pain, and others.
Regional Insights:
For detailed understanding of market dynamics, On the basis of region, the opioids market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
The market in North America is expected to account for major revenue share as compared to that of other regions. This can be attributed to increasing palliative care facilities, reformed regulations for prescription of opioids, and extensive focus of generic manufacturers towards Abuse-Deterrent Formulation (ADF) in the countries of the region. Also, the market in Europe is expected to account for second-highest revenue share in the global market, followed by the market in Asia Pacific.
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 – 2034 |
|
Market Segmentation |
By Drug Type: Agonist (Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone) and Antagonist (Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine) By Therapeutic Application: Pain Management and Cough Treatment |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Opioids Market, By Drug Class:
§ Agonist
· Codeine
· Fentanyl
· Meperidine
· Methadone
· Morphine
· Hydrocodone
· Diphenoxylate
· Hydromorphone
· Methylphenidate
· Oxycodone
· Oxymorphone
§ Antagonist
· Buprenorphine
· Naloxone
· Naltrexone
· Methylnaltrexone
· Nalbuphine
Opioids Market, By Therapeutic Application:
§ Pain Management
· Neuropathic Pain
· Migraine
· Back Pain
· Osteoarthritis Pain
· Cancer Pain
· Others
§ Cough Treatment
§ Diarrhea Treatment
Opioids Market, By Region:
o North America
§ North America Opioids Market, By Drug Class
§ North America Opioids Market, By Therapeutic Application
§ North America Opioids Market, By Country
Ø U.S.
Ø Canada
o Europe
§ Europe Opioids Market, By Drug Class
§ Europe Opioids Market, By Therapeutic Application
§ Europe Opioids Market, By Country
Ø Germany
Ø UK
Ø France
Ø Russia
Ø Italy
Ø Switzerland
Ø Sweden
Ø Rest of Europe
o Asia-Pacific
§ Asia-PacificOpioids Market, By Drug Class
§ Asia-PacificOpioids Market, By Therapeutic Application
§ Asia-PacificOpioids Market, By Country
Ø China
Ø India
Ø Australia & New Zealand
Ø Japan
Ø South Korea
Ø Rest of Asia Pacific
o Latin America
§ Latin AmericaOpioids Market, By Drug Class
§ Latin AmericaOpioids Market, By Therapeutic Application
§ Latin AmericaOpioids Market, By Country
Ø Brazil
Ø Mexico
Ø Argentina and Chile
Ø Rest of Latin America
o Middle East
§ Middle East Opioids Market, By Drug Class
§ Middle East Opioids Market, By Therapeutic Application
§ Middle East Opioids Market, By Country
Ø GCC
Ø Israel
Ø Saudi Arabia
Ø UAE
Ø Rest of Middle East
o Africa
§ Africa Opioids Market, By Drug Class
§ Africa Opioids Market, By Therapeutic Application
§ Africa Opioids Market, By Country
Ø North Africa
Ø Central Africa
Ø South Africa
Global Opioids Market By Drug Competitive Landscape & Key Players
Key players operating in the opiods market includes Sanofi, Purdue Pharma, Boehringer Ingelheim, Titan pharmaceuticals, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Egalet Corporation, Endo Pharmaceuticals Inc., Allergan Plc., and Pfizer Inc.
Global Opioids Market By Drug Company Profile
- Sanofi
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Purdue Pharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Boehringer Ingelheim
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Titan pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Sun Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Mallinckrodt Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Egalet Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Endo Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Allergan, Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
Global Opioids Market By Drug Highlights
FAQs
The opioids market is segmented based on product type, receptor binding, application, and region.
The rising prevalence of the orthopedic diseases and chronic pain, opioids plays the role of pain killer which is the major propelling factor for the growth of the market.
North America region dominates the opioids market. The united states have more opioids consumption rate.
Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the Product Types to gain a competitive edge in the target market. For instance, in 2018, Allergan acquired Elastagen, to the manufacturer of skin augmentation products.